In a high-throughput screening program in NSCLC, miR-155 was upregulated only in EGFR/KRAS negative group, miR-25 was upregulated only in EGFR positive group and miR-495 was upregulated only in KRAS positive adenocarcinomas [211]. Here, KRAS is linked to adenocarcinoma.